Allergen Immunotherapy: Dose Adjustment are Needed for Local Reactions, Peaks of Season, and Gaps in Treatment

This course if part of the 2017 Virtual Annual Meeting.  Want more virtual meeting recordings?  Save by ordering the full set!

Session 2551 from the 2017 AAAAI Annual Meeting addresses contrasting positions in the area of dose adjustments for SCIT for three separate areas: 1) local reactions, 2) peaks of pollen seasons and 3) gaps in time between injection visits and with new vials.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss whether immunotherapy doses need to be altered for local reactions, during peak pollen seasons and with gaps in therapy or with new maintenance vials
  • Discuss whether or not large local reactions predict anaphylaxis
Summary
Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.
Course opens: 
05/31/2017
Course expires: 
05/31/2019
Cost:
$25.00
Part of: 
Immunotherapy - 2017 Virtual Annual Meeting Recordings
Rating: 
0

Faculty
Dr. Tolly Epstein, MD MS FAAAAI
University of Cinncinati, Cinncinati, OH
Relevant relationships: Consultant: Merck, data review board

Dr. Mike Tankersley, MD FAAAAI
University of Tennessee Health Sciences Center, Memphis, TN
Relevant relationships: None

Reviewers
Robert Corriel, MD FAAAAI
Manhasset Allergy and Asthma Associates, Manhasset, NY
Relevant relationships: None

Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Merck, MEDA and Novartis: speakers bureau

Disclosure link: 
2017 Annual Meeting Planning, Review and Faculty Disclosures

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.